| Serial Number | 79407348 |
| Word Mark | FOSUN PHARMA |
| Filing Date | Friday, July 5, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, August 19, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, August 19, 2025 |
| Description of Mark | The mark consists of the stylized wording FOSUNPHARMA. |
| Goods and Services | Antiseptics; chemico-pharmaceutical preparations for the treatment of infectious-related diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, metabolic diseases, anti-viral diseases, oncologic diseases; anaesthetics; pharmaceutical preparations for the treatment of infectious-related diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, metabolic diseases, anti-viral diseases, oncologic diseases; vaccines; anti-inflammatory preparations; pharmaceuticals for the treatment of infectious diseases; pharmaceutical preparations to be inhaled for the prevention and treatment of respiratory diseases and disorders; pharmaceuticals for the treatment of cancer; balsamic preparations for medical purposes; drugs for medical purposes being pharmaceutical preparations for the treatment of infectious-related diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, metabolic diseases, anti-viral diseases, oncologic diseases; biological preparations for medical purposes being pharmaceutical preparations for the treatment of infectious-related diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, metabolic diseases, anti-viral diseases, oncologic diseases; medicines for human purposes being pharmaceutical preparations for the treatment of infectious-related diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, metabolic diseases, anti-viral diseases, oncologic diseases; diagnostic reagents for medical purposes; pharmaceuticals for the treatment of viral diseases; diagnostic preparations for medical purposes |
| Goods and Services | Retail store or wholesale store services for medical supplies; retail store or wholesale store services for medicines; retail store or wholesale store services for pharmaceutical preparations; marketing services; sales promotion for others |
| NOT AVAILABLE | "PHARMA" |
| Goods and Services | Medical apparatus and instruments for use in treating all treatable diseases, illnesses, and medical conditions for humans |
| Goods and Services | Pharmaceutical drug development; pharmaceutical research; conducting clinical trials for others |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 24, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 24, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 24, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 24, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Party Name | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Event Date | Event Description |
| Thursday, October 24, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, October 25, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, October 25, 2024 | APPLICATION FILING RECEIPT MAILED |
| Sunday, December 29, 2024 | ASSIGNED TO EXAMINER |
| Thursday, April 3, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, April 3, 2025 | REFUSAL PROCESSED BY MPU |
| Thursday, February 27, 2025 | NON-FINAL ACTION WRITTEN |
| Friday, February 28, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, July 7, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, April 19, 2025 | REFUSAL PROCESSED BY IB |
| Monday, July 7, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, July 7, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, July 15, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, August 13, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 19, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Friday, October 3, 2025 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, August 19, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 15, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, July 15, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, July 15, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, July 15, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |